MEDICLIN AG/ DE0006595101 /
| 2024-04-19 3:16:17 PM | Chg. +0.020 | Volume | Bid4:19:32 PM | Ask3:16:17 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.720EUR | +0.74% | 2,510 Turnover: 6,784.140 |
2.720Bid Size: 3,177 | 2.880Ask Size: 3,869 | 121.6 mill.EUR | 0.00% | 85.33 |
Assets
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 145.6000 | 146.8000 | 150.3000 | 154.6000 | 161.6000 | ||||||
| Intangible Assets | 2 | 2 | 2.4000 | 1.9000 | 1.6000 | ||||||
| Long-Term Investments | 2.1000 | 1.5000 | 1.5000 | 1.6000 | 1.6000 | ||||||
| Fixed Assets | 203 | 200 | 205.7000 | 212.5000 | 222.3000 | ||||||
| Inventories | 5.8000 | 6.5000 | 6.5000 | 6.8000 | 7.1000 | ||||||
| Accounts Receivable | 54 | 56.3000 | 61.6000 | 58.1000 | 59.8000 | ||||||
| Cash and Cash Equivalents | 57.4000 | 58.5000 | 48 | 41.3000 | 22.9000 | ||||||
| Current Assets | 134.5000 | 128.6000 | 125.6000 | 116.3000 | 97.3000 | ||||||
| Total Assets | 343.1000 | 333.8000 | 336.4000 | 328.8000 | 319.6000 | ||||||
Liabilities
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 14.6000 | 14.8000 | 15.2000 | 14.6000 | 17.3000 | ||||||
| Long-term debt | 21.1000 | 16.1000 | 20.8000 | 22.7000 | 67 | ||||||
| Liabilities to Banks | 95 | 83.1000 | 87.7000 | 90 | 75.9000 | ||||||
| Provisions | 45 | 43.4000 | 43.9000 | 40.2000 | 48.1000 | ||||||
| Liabilities | 194.3000 | 176.5000 | 171.4000 | 163.2000 | 162.6000 | ||||||
| Share Capital | 47.3000 | 47.5000 | 47.5000 | 47.5000 | 47.5000 | ||||||
| Total Equity | 148.8000 | 157.3000 | 165 | 165.6000 | 157 | ||||||
| Minority Interests | 0.0000 | 0.0000 | .1000 | 0.0000 | -.1000 | ||||||
| Total liabilities equity | 343.1000 | 333.8000 | 336.4000 | 328.8000 | 319.6000 | ||||||
Income Statement
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 456.8000 | 470.6000 | 487.2000 | 493.6000 | 509.7000 | ||||||
| Depreciation (total) | 12.1000 | 14.1000 | 13.8000 | 16.7000 | 17.3000 | ||||||
| Operating Result | 15.8000 | 17 | 16.9000 | 10.9000 | 4.3000 | ||||||
| Interest Income | -6.7000 | -5.3000 | -5.3000 | -5.1000 | -5 | ||||||
| Income Before Taxes | 9.1000 | 11.6000 | 11.6000 | 5.7000 | -.8000 | ||||||
| Income Taxes | 1.9000 | 1.3000 | 1.5000 | 2.8000 | .7000 | ||||||
| Minority Interests Profit | -.2000 | -.1000 | -.1000 | 0.0000 | .1000 | ||||||
| Net Income | 7.1000 | 10.3000 | 10 | 3 | -1.4000 | ||||||
Per Share
Cash Flow
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 21.5000 | 32.3000 | 13.4000 | 15.6000 | 16.2000 | ||||||
| Cash Flow from Investing Activities | -2.5000 | -15.3000 | -16.1000 | -22.2000 | -20.4000 | ||||||
| Cash Flow from Financing | 14.1000 | -15.9000 | -7.9000 | 0.0000 | -14.2000 | ||||||
| Decrease / Increase in Cash | 36 | 1.1000 | -10.6000 | -6.6000 | -18.4000 | ||||||
| Employees | 5,816 | 5,834 | 5,984 | 6,099 | 6,256 | ||||||
